Clinical activity of patupilone in patients with pretreated advanced/metastatic colon cancer: results of a phase I dose escalation trial

被引：0
|
作者：
B Melichar
E Casado
J Bridgewater
J Bennouna
M Campone
P Vitek
J-P Delord
J Cerman
R Salazar
J Dvorak
C Sguotti
P Urban
K Viraswami-Appanna
E Tan
J Tabernero
机构：
[1] Charles University Medical School and Teaching Hospital,Department of Oncology
[2] Palackỳ University Medical School and Teaching Hospital,Medical Oncology Department
[3] Vall d’Hebron University Hospital,undefined
[4] Universitat Autònoma de Barcelona,undefined
[5] University College London Cancer Institute,undefined
[6] Centre de Recherche en Cancérologie,undefined
[7] UMR-INSERM 892,undefined
[8] Institut de Cancérologie de l’Ouest/René Gauducheau,undefined
[9] Bd. Jacques Monod,undefined
[10] Institute of Radiation Oncology,undefined
[11] Charles University First Medical School,undefined
[12] Institut Claudius Regaud,undefined
[13] 20-24 rue de Pont Saint Pierre,undefined
[14] Novartis Pharma AG,undefined
[15] Oncology Clinical Development,undefined
[16] Novartis Pharmaceuticals Corporation,undefined
[17] One Health Plaza,undefined
来源：
British Journal of Cancer | 2011年 / 105卷
关键词：
dose escalation; epothilone B; metastatic colon cancer; microtubule stabiliser; patupilone;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1646 / 1653
页数：7
相关论文
共 50 条
  • [1] Clinical activity of patupilone in patients with pretreated advanced/metastatic colon cancer: results of a phase I dose escalation trial
    Melichar, B.
    Casado, E.
    Bridgewater, J.
    Bennouna, J.
    Campone, M.
    Vitek, P.
    Delord, J-P
    Cerman, J., Jr.
    Salazar, R.
    Dvorak, J.
    Sguotti, C.
    Urban, P.
    Viraswami-Appanna, K.
    Tan, E.
    Tabernero, J.
    [J]. BRITISH JOURNAL OF CANCER, 2011, 105 (11) : 1646 - 1653
  • [2] Phase I dose optimization trial of patupilone in previously treated patients (pts) with advanced colon cancer
    Melichar, Bohuslav
    Casado, Esther
    Tabemero, Josep
    Hosseinzadeh, Sharareh
    Hamm, John
    Wadler, Scott
    Bridgewater, John
    Holland, Jaymes
    Sklenar, Ivo
    Johri, Anandhi
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 85 - 85
  • [3] Phase I dose optimization trial of patupilone in previously treated patients (pts) with advanced colon cancer (ACC).
    Melichar, B
    Tabernero, J
    Casado, E
    Bridgewater, J
    Hamm, J
    Sklenar, I
    Holland, J
    Cheung, W
    Zaknoen, S
    Johri, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 292S - 292S
  • [4] Patupilone in patients with pretreated metastatic/locally recurrent colorectal cancer: results of the Phase II CINATRA trial
    S. Y. Moorcraft
    I. Chau
    C. Peckitt
    D. Cunningham
    S. Rao
    K. L. Yim
    A. Walther
    C. G. C. A. Jackson
    G. Stamp
    J. Webb
    G. Smith
    A. Gillbanks
    C. Swanton
    [J]. Investigational New Drugs, 2013, 31 : 1339 - 1344
  • [5] Patupilone in patients with pretreated metastatic/locally recurrent colorectal cancer: results of the Phase II CINATRA trial
    Moorcraft, S. Y.
    Chau, I.
    Peckitt, C.
    Cunningham, D.
    Rao, S.
    Yim, K. L.
    Walther, A.
    Jackson, C. G. C. A.
    Stamp, G.
    Webb, J.
    Smith, G.
    Gillbanks, A.
    Swanton, C.
    [J]. INVESTIGATIONAL NEW DRUGS, 2013, 31 (05) : 1339 - 1344
  • [6] Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer
    Bayet-Robert, Mathilde
    Kwiatkowski, Fabrice
    Leheurteur, Marianne
    Gachon, Francoise
    Planchat, Eloise
    Abrial, Catherine
    Mouret-Reynier, Marie-Ange
    Durando, Xavier
    Barthomeuf, Chantal
    Chollet, Philippe
    [J]. CANCER BIOLOGY & THERAPY, 2010, 9 (01) : 8 - 14
  • [7] Phase I trial of patupilone plus carboplatin in patients with advanced cancer
    Gore, Martin
    Kaye, Stan
    Oza, Amit
    Keyzor, Carmel
    Pyle, Linda
    Pereno, Raffaele
    Sklenar, Ivo
    Johri, Anandhi
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 126 - 127
  • [8] Phase I trial of fruquintinib in patients with advanced solid tumors; Results of the dose escalation phase
    Wang-Gillam, A.
    Yeckes-Rodin, H.
    Kosmo, M. A.
    Stanton, T.
    Park, H.
    Songhua, F.
    Sauter, N. P.
    Kania, M.
    [J]. ANNALS OF ONCOLOGY, 2019, 30 : 175 - +
  • [9] Phase I trial of patupilone plus carboplatin in patients with advanced cancer.
    Gore, M
    Kaye, S
    Oza, A
    Keyzor, C
    Pyle, L
    Pereno, R
    Sklenar, I
    Zaknoen, S
    Johri, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 476S - 476S
  • [10] Phase I/II dose-escalation trial of patupilone every 3 weeks in patients with resistant/refractory ovarian cancer
    Smit, W. M.
    Sufliarsky, J.
    Spanik, S.
    Wagnerova, M.
    Kaye, S.
    Oza, A. M.
    Gore, M.
    Williams, K. J.
    Johri, A.
    Huinink, W. W. ten Bokkel
    [J]. EJC SUPPLEMENTS, 2005, 3 (02): : 261 - 262
12345